CV_Sciences_logo2021.png
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
04 avr. 2018 08h45 HE | CV Sciences, Inc.
Company Further Reduces Debt and Avoids Dilution to Stockholders LAS VEGAS, April 04, 2018 (GLOBE NEWSWIRE) --  CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”)...
CV_Sciences_logo2021.png
CV Sciences, Inc. to Host Fourth Quarter and Year End 2017 Financial Results Conference Call on Thursday, March 29, 2018
22 mars 2018 19h00 HE | CV Sciences, Inc.
LAS VEGAS, March 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, today announced that it is...
CV_Sciences_logo2021.png
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
06 mars 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, March 06, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the February and March 2018 installment...
CV_Sciences_logo2021.png
CV Sciences, Inc. to Present at the 30th Annual ROTH Conference in Dana Point, California, March 11-14, 2018
28 févr. 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that it...
CV_Sciences_logo2021.png
CV Sciences, Inc. to Exhibit and Present at the 2018 Integrative Health Symposium Annual Conference in New York, New York – February 22-24, 2018
24 janv. 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Jan. 24, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting its industry-dominating brand of...
CV_Sciences_logo2021.png
CV Sciences, Inc. to Present at the Biotech Showcase™ 2018
03 janv. 2018 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids,...
CV_Sciences_logo2021.png
CV Sciences, Inc. to Exhibit at the 25th Annual World Congress on Anti-Aging Medicine in Las Vegas, NV - December 14-16th, 2017
12 déc. 2017 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Dec. 12, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting at the 25th Annual World...
CV_Sciences_logo2021.png
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
05 déc. 2017 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the December 2017 installment obligation...
CV_Sciences_logo2021.png
CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017
21 nov. 2017 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017 Company enters its 3rd year exhibiting its...
CV_Sciences_logo2021.png
CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™
14 nov. 2017 08h45 HE | CV Sciences, Inc.
LAS VEGAS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty...